An open-label extension study of lurasidone in patients with schizophrenia previously randomized to lurasidone or risperidone

被引：0
|
作者：
Mattingly, G. [1 ]
Tocco, M. [2 ]
Cucchiaro, J. [3 ]
Xu, J. [3 ]
Pikalov, A. [3 ]
Loebel, A. [3 ]
机构：
[1] St Charles Psychiat Associates, St Charles, MO USA
[2] Sunov Pharmaceut Inc, Marlborough, MA USA
[3] Sunov Pharmaceut Inc, Ft Lee, VA USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70895-8
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.062
引用
收藏
页码：S559 / S559
页数：1
相关论文
共 50 条
  • [31] Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study
    Mattingly, Greg W.
    Haddad, Peter M.
    Tocco, Michael
    Xu, Jane
    Phillips, Debra
    Pikalov, Andrei
    Loebel, Antony
    BMC PSYCHIATRY, 2020, 20 (01)
  • [32] LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: REMISSION AND RECOVERY DURING 2 YEARS OF OPEN-LABEL TREATMENT
    Tocco, Michael
    Pikalov, Andrei A.
    Deng, Ling
    Goldman, Robert S.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S254 - S254
  • [33] Lurasidone in adolescents with schizophrenia: remission and recovery during 2 years of open-label treatment
    Tocco, M.
    Pikalov, A.
    Ling, D.
    Goldman, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S318 - S318
  • [34] LONG-TERM SAFETY AND TOLERABILITY OF LURASIDONE IN PATIENTS WITH SCHIZOPHRENIA: RESULTS OF A 6-MONTH, OPEN-LABEL STUDY
    Stahl, Steven M.
    Cucchiaro, Josephine
    Simonelli, D.
    Severs, J.
    Loebel, A.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 322 - 322
  • [35] LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: REMISSION AND RECOVERY DURING 2 YEARS OF OPEN-LABEL TREATMENT
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Goldman, R.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (1_SUPPL): : 104 - 104
  • [36] LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY
    Ketter, Terence A.
    Sarma, Kaushik
    Silva, Robert
    Kroger, Hans
    Cucchiaro, Josephine
    Loebel, Antony
    DEPRESSION AND ANXIETY, 2016, 33 (05) : 424 - 434
  • [37] Effect of lurasidone on cognition in adolescents with schizophrenia: A one-year interim analysis of a 2-year open-label extension study
    Harvey, P. D.
    Goldman, R.
    Tocco, M.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S123 - S123
  • [38] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    Coghill, D.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 105 - 105
  • [39] Safety and effectiveness of lurasidone in adolescents with schizophrenia: A one-year interim analysis of a 2-year open-label extension study
    Correll, C.
    Tocco, M.
    Goldman, R.
    Pikalov, A.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S127 - S127
  • [40] Effect of food on the pharmacokinetics of lurasidone: results of two randomized, open-label, crossover studies
    Preskorn, Sheldon
    Ereshefsky, Larry
    Chiu, Yu-Yuan
    Poola, Nagaraju
    Loebel, Antony
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2013, 28 (05) : 495 - 505
12345